The immunogenicity and reactogenicity of the trivalent vaccine, Trimovax, indicated for prevention of measles, mumps, and rubella, in 12-month-old children in Belarus.
Year: 2000
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: E O Samoilovich, L A Kapustik, E V Feldman, M A Yermolovich, A J Svirchevskaya, D F Zakharenko, M A Fletcher, L P Titov
Language: English
Topic: Virology and Viral Diseases
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W171972715